Announcements Trials

Browse Landscape

Phase

Status

Recruiting 2 Completed 2 Unknown 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pelvic Mass 1 Neoplasms 1 Hemorrhage 1

Interventions

pembrolizumab 25 Cyclophosphamide 20 Nivolumab 13 Doxorubicin 13 Carboplatin 10 Surveys and Questionnaires 9 Paclitaxel 9 Exercise 9 atezolizumab 8 Vincristine 8 Rituximab 8 Radiotherapy 8 Prednisone 8 Dexamethasone 8 Bevacizumab 8 venetoclax 7 fludarabine 7 Pemetrexed 7 Fluorouracil 7 Docetaxel 7 Blood Specimen Collection 7 lenvatinib 6 dostarlimab 6 cemiplimab 6 budigalimab 6 Oxaliplatin 6 Cisplatin 6 durvalumab 5 Leucovorin 5 Lenalidomide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Neoplasms × Tranexamic Acid × Clear all

NCT02261415 2022-10-26

HeLiX

Sunnybrook Health Sciences Centre

Phase 3 Active not recruiting

Hemorrhage, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡